Recombinant DNA Advisory Committee - 10/16/90 
I. CALL TO ORDER AND OPENING REMARKS; 
Dr. Gerard G. McGarrity (Chair) called the meeting of the 
Recombinant DNA Advisory Committee (RAC) to order at 9:00 a.m. , 
on October 16, 1990. He said a notice of the meeting had been 
published in the Federal Register and that a quorum was present. 
He noted the meeting would be short in comparison to other RAC 
meetings and called attention to the agenda. He explained that 
in recognizing people to speak he would do so in the following 
order: primary reviewers, secondary reviewers, other members of 
the RAC, other members of NIH and other Federal Government 
agencies, and then members of the general public. He noted that 
the RAC is advisory to the Director of NIH and that times as 
published on the agenda were tentative. 
Dr. McGarrity noted that Drs. Clewell, Erickson, Childress 
Mulligan and Riley, as well as Mr. earner, were attending their 
final meeting as members of the RAC. He noted, however, that due 
to the process of replacement, they may need to attend future 
meetings as their term does not officially end until a 
replacement has been selected by the Secretary of the Department 
of Health and Human Services. He thanked them for their service 
on behalf of the Department, the Public Health Service, the 
National Institutes of Health, and offered personal thanks for 
the support and counsel they had offered him during his tenure as 
Chairman. 
II. MINUTES OF JULY 31. 1990 MEETING; 
Dr. McGarrity then called the committee's attention to tab 1406, 
and called on Dr. Mclvor for his comments on the minutes of the 
meeting of the RAC which took place on July 31, 1990. Dr. Mclvor 
said he had read the minutes and found them to reflect his 
recollection of the meeting. However, he noted that it had been 
suggested at the meeting that certain relevant portions of the 
minutes of the Human Gene Therapy Subcommittee meeting were to be 
included as Appendices B, C, and D to the minutes of the full RAC 
meeting and noted that they were not included at present. He 
moved the minutes be approved pending the addition of those 
appendices. 
Dr. Wivel noted that the minutes of the Human Gene Therapy 
Subcommittee meetings are reviewed in a less formal manner than 
the minutes of the RAC meeting and that this review had not taken 
place. He assured the committee that as soon as this review was 
completed by the Chair of the Human Gene Therapy Subcommittee, 
the material would be appended to the minutes of the July 31, 
1990 RAC meeting. 
Mr. Brewer said he had a small word change which he would discuss 
[338] 
Recombinant DNA Research, Volume 14 
